BridgeBio Pharma BBIO Earnings Call Transcripts

NASDAQ BBIO
$79.54 +0.87 (+1.11%)
At close: Nov 11, 2026 · 4:00 PM EST
6 earnings calls on file for BridgeBio Pharma, from Q2 2025 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

BridgeBio Pharma Q3 2026 Earnings Call

Oct 29, 2026 9,433 words · 41 min read
  • Chinmay ShuklaChief Business Officer
  • Neil KumarChief Executive Officer
  • Matthew OuttenChief Commercial Officer
  • Thomas TrimarchiPresident and Chief Financial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

BridgeBio Pharma Earnings Call Transcripts

Calls6
LatestOct 29, 2026
SinceQ2 2025

Fiscal 2026

Fiscal 2025

All 6 BridgeBio Pharma transcripts Register to get access to BridgeBio Pharma’s earnings call transcripts.